1例血小板减少合并急性心肌梗死患者抗血栓药物应用分析

Analysis of Antithrombotic Drugs Application in One Patient with Thrombocytopenia and Acute Myocardial Infarction

目的:探讨血小板减少合并急性心肌梗死患者抗血栓药物的应用。方法:对1例原发性免疫性血小板减少症患者发生急性心肌梗死的诊治过程分析讨论,查阅相关文献,总结此类病例特点、抗血小板、抗凝药物的应用情况及不良事件。结果:该病例的抗栓药物治疗方案调整合理。结论:合并血小板减少的患者发生急性心肌梗死时进行抗凝抗血小板治疗安全性较好,如合并其他疾病,应根据具体情况给予个体化抗栓治疗。

Objective： To discuss the application of antithrombotic drags in myocardial infarction patients with thrombocytopenia. Methods： The therapy for one myocardial infarction patient with primary thrombocytopenia was discussed and summarized. Based on the related literatures, the characteristics of case, application status and adverse reactions of antithrombotic drugs and anticoagulant drugs were summarized. Results： The adjustment of antithrombotic drug treatment regimen for the patient was reasonable. Condu- sion： Antithrombotic drugs applied in acute myocardial infarction patients with thrombocytopenia are safe. ff patients complicate with other diseases, individualized antithrombotic therapy should be carried out according to particular case.